Dendritic Cell Vaccine Market, Global Outlook and Forecast 2022-2028

July 2022 | 119 pages | ID: DFC2CE0B194BEN
Market Monitor Global

Abstracts

Dendritic cells (DCs) have several characteristics that make them an ideal vehicle for tumor vaccines, and with the first US FDA-approved DC-based vaccine in use for the treatment of prostate cancer, this technology has become a promising new therapeutic option.

This report contains market size and forecasts of Dendritic Cell Vaccine in global, including the following market information:

Global Dendritic Cell Vaccine Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Dendritic Cell Vaccine Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Dendritic Cell Vaccine companies in 2021 (%)

The global Dendritic Cell Vaccine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Non-Targeted Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Dendritic Cell Vaccine include 3M, Activarti, Argos Therapeutics, Batavia Bioservices, Bellicum Pharmaceuticals, Creagene, DanDrit Biotech, DCPrime and Sanpower Corporation (Dendreon Corporation), etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Dendritic Cell Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Dendritic Cell Vaccine Market, By Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Dendritic Cell Vaccine Market Segment Percentages, By Type, 2021 (%)

• Non-Targeted
• Target

Global Dendritic Cell Vaccine Market, By Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Dendritic Cell Vaccine Market Segment Percentages, By Application, 2021 (%)

• Covid-19
• Cancer
• Others

Global Dendritic Cell Vaccine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Dendritic Cell Vaccine Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Dendritic Cell Vaccine revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Dendritic Cell Vaccine revenues share in global market, 2021 (%)

Key companies Dendritic Cell Vaccine sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Dendritic Cell Vaccine sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• 3M
• Activarti
• Argos Therapeutics
• Batavia Bioservices
• Bellicum Pharmaceuticals
• Creagene
• DanDrit Biotech
• DCPrime
• Sanpower Corporation (Dendreon Corporation)
• Elios Therapeutics
• ImmunoCellular Therapeutics
• Immunicum
• Kiromic
• Medigene
• Merck & Co.
• Northwest Biotherapeutics
• Glaxo Smith Kline
• Tella Incorporation
• Vaxil BioTherapeutics

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Dendritic Cell Vaccine Market Definition
1.2 Market Segments
  1.2.1 Market By Type
  1.2.2 Market By Application
1.3 Global Dendritic Cell Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL DENDRITIC CELL VACCINE OVERALL MARKET SIZE

2.1 Global Dendritic Cell Vaccine Market Size: 2021 VS 2028
2.2 Global Dendritic Cell Vaccine Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Dendritic Cell Vaccine Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top Dendritic Cell Vaccine Players in Global Market
3.2 Top Global Dendritic Cell Vaccine Companies Ranked by Revenue
3.3 Global Dendritic Cell Vaccine Revenue by Companies
3.4 Global Dendritic Cell Vaccine Sales by Companies
3.5 Global Dendritic Cell Vaccine Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Dendritic Cell Vaccine Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Dendritic Cell Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Dendritic Cell Vaccine Players in Global Market
  3.8.1 List of Global Tier 1 Dendritic Cell Vaccine Companies
  3.8.2 List of Global Tier 2 and Tier 3 Dendritic Cell Vaccine Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Dendritic Cell Vaccine Market Size Markets, 2021 & 2028
  4.1.2 Non-Targeted
  4.1.3 Target
4.2 By Type - Global Dendritic Cell Vaccine Revenue & Forecasts
  4.2.1 By Type - Global Dendritic Cell Vaccine Revenue, 2017-2022
  4.2.2 By Type - Global Dendritic Cell Vaccine Revenue, 2023-2028
  4.2.3 By Type - Global Dendritic Cell Vaccine Revenue Market Share, 2017-2028
4.3 By Type - Global Dendritic Cell Vaccine Sales & Forecasts
  4.3.1 By Type - Global Dendritic Cell Vaccine Sales, 2017-2022
  4.3.2 By Type - Global Dendritic Cell Vaccine Sales, 2023-2028
  4.3.3 By Type - Global Dendritic Cell Vaccine Sales Market Share, 2017-2028
4.4 By Type - Global Dendritic Cell Vaccine Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Dendritic Cell Vaccine Market Size, 2021 & 2028
  5.1.2 Covid-19
  5.1.3 Cancer
  5.1.4 Others
5.2 By Application - Global Dendritic Cell Vaccine Revenue & Forecasts
  5.2.1 By Application - Global Dendritic Cell Vaccine Revenue, 2017-2022
  5.2.2 By Application - Global Dendritic Cell Vaccine Revenue, 2023-2028
  5.2.3 By Application - Global Dendritic Cell Vaccine Revenue Market Share, 2017-2028
5.3 By Application - Global Dendritic Cell Vaccine Sales & Forecasts
  5.3.1 By Application - Global Dendritic Cell Vaccine Sales, 2017-2022
  5.3.2 By Application - Global Dendritic Cell Vaccine Sales, 2023-2028
  5.3.3 By Application - Global Dendritic Cell Vaccine Sales Market Share, 2017-2028
5.4 By Application - Global Dendritic Cell Vaccine Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Dendritic Cell Vaccine Market Size, 2021 & 2028
6.2 By Region - Global Dendritic Cell Vaccine Revenue & Forecasts
  6.2.1 By Region - Global Dendritic Cell Vaccine Revenue, 2017-2022
  6.2.2 By Region - Global Dendritic Cell Vaccine Revenue, 2023-2028
  6.2.3 By Region - Global Dendritic Cell Vaccine Revenue Market Share, 2017-2028
6.3 By Region - Global Dendritic Cell Vaccine Sales & Forecasts
  6.3.1 By Region - Global Dendritic Cell Vaccine Sales, 2017-2022
  6.3.2 By Region - Global Dendritic Cell Vaccine Sales, 2023-2028
  6.3.3 By Region - Global Dendritic Cell Vaccine Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America Dendritic Cell Vaccine Revenue, 2017-2028
  6.4.2 By Country - North America Dendritic Cell Vaccine Sales, 2017-2028
  6.4.3 US Dendritic Cell Vaccine Market Size, 2017-2028
  6.4.4 Canada Dendritic Cell Vaccine Market Size, 2017-2028
  6.4.5 Mexico Dendritic Cell Vaccine Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe Dendritic Cell Vaccine Revenue, 2017-2028
  6.5.2 By Country - Europe Dendritic Cell Vaccine Sales, 2017-2028
  6.5.3 Germany Dendritic Cell Vaccine Market Size, 2017-2028
  6.5.4 France Dendritic Cell Vaccine Market Size, 2017-2028
  6.5.5 U.K. Dendritic Cell Vaccine Market Size, 2017-2028
  6.5.6 Italy Dendritic Cell Vaccine Market Size, 2017-2028
  6.5.7 Russia Dendritic Cell Vaccine Market Size, 2017-2028
  6.5.8 Nordic Countries Dendritic Cell Vaccine Market Size, 2017-2028
  6.5.9 Benelux Dendritic Cell Vaccine Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia Dendritic Cell Vaccine Revenue, 2017-2028
  6.6.2 By Region - Asia Dendritic Cell Vaccine Sales, 2017-2028
  6.6.3 China Dendritic Cell Vaccine Market Size, 2017-2028
  6.6.4 Japan Dendritic Cell Vaccine Market Size, 2017-2028
  6.6.5 South Korea Dendritic Cell Vaccine Market Size, 2017-2028
  6.6.6 Southeast Asia Dendritic Cell Vaccine Market Size, 2017-2028
  6.6.7 India Dendritic Cell Vaccine Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America Dendritic Cell Vaccine Revenue, 2017-2028
  6.7.2 By Country - South America Dendritic Cell Vaccine Sales, 2017-2028
  6.7.3 Brazil Dendritic Cell Vaccine Market Size, 2017-2028
  6.7.4 Argentina Dendritic Cell Vaccine Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Dendritic Cell Vaccine Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa Dendritic Cell Vaccine Sales, 2017-2028
  6.8.3 Turkey Dendritic Cell Vaccine Market Size, 2017-2028
  6.8.4 Israel Dendritic Cell Vaccine Market Size, 2017-2028
  6.8.5 Saudi Arabia Dendritic Cell Vaccine Market Size, 2017-2028
  6.8.6 UAE Dendritic Cell Vaccine Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 3M
  7.1.1 3M Corporate Summary
  7.1.2 3M Business Overview
  7.1.3 3M Dendritic Cell Vaccine Major Product Offerings
  7.1.4 3M Dendritic Cell Vaccine Sales and Revenue in Global (2017-2022)
  7.1.5 3M Key News
7.2 Activarti
  7.2.1 Activarti Corporate Summary
  7.2.2 Activarti Business Overview
  7.2.3 Activarti Dendritic Cell Vaccine Major Product Offerings
  7.2.4 Activarti Dendritic Cell Vaccine Sales and Revenue in Global (2017-2022)
  7.2.5 Activarti Key News
7.3 Argos Therapeutics
  7.3.1 Argos Therapeutics Corporate Summary
  7.3.2 Argos Therapeutics Business Overview
  7.3.3 Argos Therapeutics Dendritic Cell Vaccine Major Product Offerings
  7.3.4 Argos Therapeutics Dendritic Cell Vaccine Sales and Revenue in Global (2017-2022)
  7.3.5 Argos Therapeutics Key News
7.4 Batavia Bioservices
  7.4.1 Batavia Bioservices Corporate Summary
  7.4.2 Batavia Bioservices Business Overview
  7.4.3 Batavia Bioservices Dendritic Cell Vaccine Major Product Offerings
  7.4.4 Batavia Bioservices Dendritic Cell Vaccine Sales and Revenue in Global (2017-2022)
  7.4.5 Batavia Bioservices Key News
7.5 Bellicum Pharmaceuticals
  7.5.1 Bellicum Pharmaceuticals Corporate Summary
  7.5.2 Bellicum Pharmaceuticals Business Overview
  7.5.3 Bellicum Pharmaceuticals Dendritic Cell Vaccine Major Product Offerings
  7.5.4 Bellicum Pharmaceuticals Dendritic Cell Vaccine Sales and Revenue in Global (2017-2022)
  7.5.5 Bellicum Pharmaceuticals Key News
7.6 Creagene
  7.6.1 Creagene Corporate Summary
  7.6.2 Creagene Business Overview
  7.6.3 Creagene Dendritic Cell Vaccine Major Product Offerings
  7.6.4 Creagene Dendritic Cell Vaccine Sales and Revenue in Global (2017-2022)
  7.6.5 Creagene Key News
7.7 DanDrit Biotech
  7.7.1 DanDrit Biotech Corporate Summary
  7.7.2 DanDrit Biotech Business Overview
  7.7.3 DanDrit Biotech Dendritic Cell Vaccine Major Product Offerings
  7.7.4 DanDrit Biotech Dendritic Cell Vaccine Sales and Revenue in Global (2017-2022)
  7.7.5 DanDrit Biotech Key News
7.8 DCPrime
  7.8.1 DCPrime Corporate Summary
  7.8.2 DCPrime Business Overview
  7.8.3 DCPrime Dendritic Cell Vaccine Major Product Offerings
  7.8.4 DCPrime Dendritic Cell Vaccine Sales and Revenue in Global (2017-2022)
  7.8.5 DCPrime Key News
7.9 Sanpower Corporation (Dendreon Corporation)
  7.9.1 Sanpower Corporation (Dendreon Corporation) Corporate Summary
  7.9.2 Sanpower Corporation (Dendreon Corporation) Business Overview
  7.9.3 Sanpower Corporation (Dendreon Corporation) Dendritic Cell Vaccine Major Product Offerings
  7.9.4 Sanpower Corporation (Dendreon Corporation) Dendritic Cell Vaccine Sales and Revenue in Global (2017-2022)
  7.9.5 Sanpower Corporation (Dendreon Corporation) Key News
7.10 Elios Therapeutics
  7.10.1 Elios Therapeutics Corporate Summary
  7.10.2 Elios Therapeutics Business Overview
  7.10.3 Elios Therapeutics Dendritic Cell Vaccine Major Product Offerings
  7.10.4 Elios Therapeutics Dendritic Cell Vaccine Sales and Revenue in Global (2017-2022)
  7.10.5 Elios Therapeutics Key News
7.11 ImmunoCellular Therapeutics
  7.11.1 ImmunoCellular Therapeutics Corporate Summary
  7.11.2 ImmunoCellular Therapeutics Dendritic Cell Vaccine Business Overview
  7.11.3 ImmunoCellular Therapeutics Dendritic Cell Vaccine Major Product Offerings
  7.11.4 ImmunoCellular Therapeutics Dendritic Cell Vaccine Sales and Revenue in Global (2017-2022)
  7.11.5 ImmunoCellular Therapeutics Key News
7.12 Immunicum
  7.12.1 Immunicum Corporate Summary
  7.12.2 Immunicum Dendritic Cell Vaccine Business Overview
  7.12.3 Immunicum Dendritic Cell Vaccine Major Product Offerings
  7.12.4 Immunicum Dendritic Cell Vaccine Sales and Revenue in Global (2017-2022)
  7.12.5 Immunicum Key News
7.13 Kiromic
  7.13.1 Kiromic Corporate Summary
  7.13.2 Kiromic Dendritic Cell Vaccine Business Overview
  7.13.3 Kiromic Dendritic Cell Vaccine Major Product Offerings
  7.13.4 Kiromic Dendritic Cell Vaccine Sales and Revenue in Global (2017-2022)
  7.13.5 Kiromic Key News
7.14 Medigene
  7.14.1 Medigene Corporate Summary
  7.14.2 Medigene Business Overview
  7.14.3 Medigene Dendritic Cell Vaccine Major Product Offerings
  7.14.4 Medigene Dendritic Cell Vaccine Sales and Revenue in Global (2017-2022)
  7.14.5 Medigene Key News
7.15 Merck & Co.
  7.15.1 Merck & Co. Corporate Summary
  7.15.2 Merck & Co. Business Overview
  7.15.3 Merck & Co. Dendritic Cell Vaccine Major Product Offerings
  7.15.4 Merck & Co. Dendritic Cell Vaccine Sales and Revenue in Global (2017-2022)
  7.15.5 Merck & Co. Key News
7.16 Northwest Biotherapeutics
  7.16.1 Northwest Biotherapeutics Corporate Summary
  7.16.2 Northwest Biotherapeutics Business Overview
  7.16.3 Northwest Biotherapeutics Dendritic Cell Vaccine Major Product Offerings
  7.16.4 Northwest Biotherapeutics Dendritic Cell Vaccine Sales and Revenue in Global (2017-2022)
  7.16.5 Northwest Biotherapeutics Key News
7.17 Glaxo Smith Kline
  7.17.1 Glaxo Smith Kline Corporate Summary
  7.17.2 Glaxo Smith Kline Business Overview
  7.17.3 Glaxo Smith Kline Dendritic Cell Vaccine Major Product Offerings
  7.17.4 Glaxo Smith Kline Dendritic Cell Vaccine Sales and Revenue in Global (2017-2022)
  7.17.5 Glaxo Smith Kline Key News
7.18 Tella Incorporation
  7.18.1 Tella Incorporation Corporate Summary
  7.18.2 Tella Incorporation Business Overview
  7.18.3 Tella Incorporation Dendritic Cell Vaccine Major Product Offerings
  7.18.4 Tella Incorporation Dendritic Cell Vaccine Sales and Revenue in Global (2017-2022)
  7.18.5 Tella Incorporation Key News
7.19 Vaxil BioTherapeutics
  7.19.1 Vaxil BioTherapeutics Corporate Summary
  7.19.2 Vaxil BioTherapeutics Business Overview
  7.19.3 Vaxil BioTherapeutics Dendritic Cell Vaccine Major Product Offerings
  7.19.4 Vaxil BioTherapeutics Dendritic Cell Vaccine Sales and Revenue in Global (2017-2022)
  7.19.5 Vaxil BioTherapeutics Key News

8 GLOBAL DENDRITIC CELL VACCINE PRODUCTION CAPACITY, ANALYSIS

8.1 Global Dendritic Cell Vaccine Production Capacity, 2017-2028
8.2 Dendritic Cell Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Dendritic Cell Vaccine Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 DENDRITIC CELL VACCINE SUPPLY CHAIN ANALYSIS

10.1 Dendritic Cell Vaccine Industry Value Chain
10.2 Dendritic Cell Vaccine Upstream Market
10.3 Dendritic Cell Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Dendritic Cell Vaccine Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Dendritic Cell Vaccine in Global Market
Table 2. Top Dendritic Cell Vaccine Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Dendritic Cell Vaccine Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Dendritic Cell Vaccine Revenue Share by Companies, 2017-2022
Table 5. Global Dendritic Cell Vaccine Sales by Companies, (K Units), 2017-2022
Table 6. Global Dendritic Cell Vaccine Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Dendritic Cell Vaccine Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Dendritic Cell Vaccine Product Type
Table 9. List of Global Tier 1 Dendritic Cell Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Dendritic Cell Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Dendritic Cell Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Dendritic Cell Vaccine Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Dendritic Cell Vaccine Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Dendritic Cell Vaccine Sales (K Units), 2017-2022
Table 15. By Type - Global Dendritic Cell Vaccine Sales (K Units), 2023-2028
Table 16. By Application – Global Dendritic Cell Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Dendritic Cell Vaccine Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Dendritic Cell Vaccine Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Dendritic Cell Vaccine Sales (K Units), 2017-2022
Table 20. By Application - Global Dendritic Cell Vaccine Sales (K Units), 2023-2028
Table 21. By Region – Global Dendritic Cell Vaccine Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Dendritic Cell Vaccine Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Dendritic Cell Vaccine Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Dendritic Cell Vaccine Sales (K Units), 2017-2022
Table 25. By Region - Global Dendritic Cell Vaccine Sales (K Units), 2023-2028
Table 26. By Country - North America Dendritic Cell Vaccine Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Dendritic Cell Vaccine Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Dendritic Cell Vaccine Sales, (K Units), 2017-2022
Table 29. By Country - North America Dendritic Cell Vaccine Sales, (K Units), 2023-2028
Table 30. By Country - Europe Dendritic Cell Vaccine Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Dendritic Cell Vaccine Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Dendritic Cell Vaccine Sales, (K Units), 2017-2022
Table 33. By Country - Europe Dendritic Cell Vaccine Sales, (K Units), 2023-2028
Table 34. By Region - Asia Dendritic Cell Vaccine Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Dendritic Cell Vaccine Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Dendritic Cell Vaccine Sales, (K Units), 2017-2022
Table 37. By Region - Asia Dendritic Cell Vaccine Sales, (K Units), 2023-2028
Table 38. By Country - South America Dendritic Cell Vaccine Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Dendritic Cell Vaccine Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Dendritic Cell Vaccine Sales, (K Units), 2017-2022
Table 41. By Country - South America Dendritic Cell Vaccine Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Dendritic Cell Vaccine Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Dendritic Cell Vaccine Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Dendritic Cell Vaccine Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Dendritic Cell Vaccine Sales, (K Units), 2023-2028
Table 46. 3M Corporate Summary
Table 47. 3M Dendritic Cell Vaccine Product Offerings
Table 48. 3M Dendritic Cell Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Activarti Corporate Summary
Table 50. Activarti Dendritic Cell Vaccine Product Offerings
Table 51. Activarti Dendritic Cell Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Argos Therapeutics Corporate Summary
Table 53. Argos Therapeutics Dendritic Cell Vaccine Product Offerings
Table 54. Argos Therapeutics Dendritic Cell Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Batavia Bioservices Corporate Summary
Table 56. Batavia Bioservices Dendritic Cell Vaccine Product Offerings
Table 57. Batavia Bioservices Dendritic Cell Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Bellicum Pharmaceuticals Corporate Summary
Table 59. Bellicum Pharmaceuticals Dendritic Cell Vaccine Product Offerings
Table 60. Bellicum Pharmaceuticals Dendritic Cell Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Creagene Corporate Summary
Table 62. Creagene Dendritic Cell Vaccine Product Offerings
Table 63. Creagene Dendritic Cell Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. DanDrit Biotech Corporate Summary
Table 65. DanDrit Biotech Dendritic Cell Vaccine Product Offerings
Table 66. DanDrit Biotech Dendritic Cell Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. DCPrime Corporate Summary
Table 68. DCPrime Dendritic Cell Vaccine Product Offerings
Table 69. DCPrime Dendritic Cell Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. Sanpower Corporation (Dendreon Corporation) Corporate Summary
Table 71. Sanpower Corporation (Dendreon Corporation) Dendritic Cell Vaccine Product Offerings
Table 72. Sanpower Corporation (Dendreon Corporation) Dendritic Cell Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 73. Elios Therapeutics Corporate Summary
Table 74. Elios Therapeutics Dendritic Cell Vaccine Product Offerings
Table 75. Elios Therapeutics Dendritic Cell Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 76. ImmunoCellular Therapeutics Corporate Summary
Table 77. ImmunoCellular Therapeutics Dendritic Cell Vaccine Product Offerings
Table 78. ImmunoCellular Therapeutics Dendritic Cell Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 79. Immunicum Corporate Summary
Table 80. Immunicum Dendritic Cell Vaccine Product Offerings
Table 81. Immunicum Dendritic Cell Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 82. Kiromic Corporate Summary
Table 83. Kiromic Dendritic Cell Vaccine Product Offerings
Table 84. Kiromic Dendritic Cell Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 85. Medigene Corporate Summary
Table 86. Medigene Dendritic Cell Vaccine Product Offerings
Table 87. Medigene Dendritic Cell Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 88. Merck & Co. Corporate Summary
Table 89. Merck & Co. Dendritic Cell Vaccine Product Offerings
Table 90. Merck & Co. Dendritic Cell Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 91. Northwest Biotherapeutics Corporate Summary
Table 92. Northwest Biotherapeutics Dendritic Cell Vaccine Product Offerings
Table 93. Northwest Biotherapeutics Dendritic Cell Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 94. Glaxo Smith Kline Corporate Summary
Table 95. Glaxo Smith Kline Dendritic Cell Vaccine Product Offerings
Table 96. Glaxo Smith Kline Dendritic Cell Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 97. Tella Incorporation Corporate Summary
Table 98. Tella Incorporation Dendritic Cell Vaccine Product Offerings
Table 99. Tella Incorporation Dendritic Cell Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 100. Vaxil BioTherapeutics Corporate Summary
Table 101. Vaxil BioTherapeutics Dendritic Cell Vaccine Product Offerings
Table 102. Vaxil BioTherapeutics Dendritic Cell Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 103. Dendritic Cell Vaccine Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 104. Global Dendritic Cell Vaccine Capacity Market Share of Key Manufacturers, 2020-2022
Table 105. Global Dendritic Cell Vaccine Production by Region, 2017-2022 (K Units)
Table 106. Global Dendritic Cell Vaccine Production by Region, 2023-2028 (K Units)
Table 107. Dendritic Cell Vaccine Market Opportunities & Trends in Global Market
Table 108. Dendritic Cell Vaccine Market Drivers in Global Market
Table 109. Dendritic Cell Vaccine Market Restraints in Global Market
Table 110. Dendritic Cell Vaccine Raw Materials
Table 111. Dendritic Cell Vaccine Raw Materials Suppliers in Global Market
Table 112. Typical Dendritic Cell Vaccine Downstream
Table 113. Dendritic Cell Vaccine Downstream Clients in Global Market
Table 114. Dendritic Cell Vaccine Distributors and Sales Agents in Global Market

List Of Figures

LIST OF FIGURES

Figure 1. Dendritic Cell Vaccine Segment By Type
Figure 2. Dendritic Cell Vaccine Segment By Application
Figure 3. Global Dendritic Cell Vaccine Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Dendritic Cell Vaccine Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Dendritic Cell Vaccine Revenue, 2017-2028 (US$, Mn)
Figure 7. Dendritic Cell Vaccine Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Dendritic Cell Vaccine Revenue in 2021
Figure 9. By Type - Global Dendritic Cell Vaccine Sales Market Share, 2017-2028
Figure 10. By Type - Global Dendritic Cell Vaccine Revenue Market Share, 2017-2028
Figure 11. By Type - Global Dendritic Cell Vaccine Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Dendritic Cell Vaccine Sales Market Share, 2017-2028
Figure 13. By Application - Global Dendritic Cell Vaccine Revenue Market Share, 2017-2028
Figure 14. By Application - Global Dendritic Cell Vaccine Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Dendritic Cell Vaccine Sales Market Share, 2017-2028
Figure 16. By Region - Global Dendritic Cell Vaccine Revenue Market Share, 2017-2028
Figure 17. By Country - North America Dendritic Cell Vaccine Revenue Market Share, 2017-2028
Figure 18. By Country - North America Dendritic Cell Vaccine Sales Market Share, 2017-2028
Figure 19. US Dendritic Cell Vaccine Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Dendritic Cell Vaccine Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Dendritic Cell Vaccine Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Dendritic Cell Vaccine Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Dendritic Cell Vaccine Sales Market Share, 2017-2028
Figure 24. Germany Dendritic Cell Vaccine Revenue, (US$, Mn), 2017-2028
Figure 25. France Dendritic Cell Vaccine Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Dendritic Cell Vaccine Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Dendritic Cell Vaccine Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Dendritic Cell Vaccine Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Dendritic Cell Vaccine Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Dendritic Cell Vaccine Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Dendritic Cell Vaccine Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Dendritic Cell Vaccine Sales Market Share, 2017-2028
Figure 33. China Dendritic Cell Vaccine Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Dendritic Cell Vaccine Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Dendritic Cell Vaccine Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Dendritic Cell Vaccine Revenue, (US$, Mn), 2017-2028
Figure 37. India Dendritic Cell Vaccine Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Dendritic Cell Vaccine Revenue Market Share, 2017-2028
Figure 39. By Country - South America Dendritic Cell Vaccine Sales Market Share, 2017-2028
Figure 40. Brazil Dendritic Cell Vaccine Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Dendritic Cell Vaccine Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Dendritic Cell Vaccine Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Dendritic Cell Vaccine Sales Market Share, 2017-2028
Figure 44. Turkey Dendritic Cell Vaccine Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Dendritic Cell Vaccine Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Dendritic Cell Vaccine Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Dendritic Cell Vaccine Revenue, (US$, Mn), 2017-2028
Figure 48. Global Dendritic Cell Vaccine Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Dendritic Cell Vaccine by Region, 2021 VS 2028
Figure 50. Dendritic Cell Vaccine Industry Value Chain
Figure 51. Marketing Channels